L. Djukanovic et al., EFFECTS OF CAPTOPRIL AND HYDRALAZINE ON PROGRESSION OF ADRIAMYCIN NEPHROPATHY IN SPONTANEOUSLY HYPERTENSIVE RATS, Israel journal of medical sciences, 30(10), 1994, pp. 742-746
The effects of captopril and hydralazine on morphologic changes and cl
inical course of adriamycin nephropathy in spontaneously hypertensive
rats (SHR) were examined. The rats were followed for 18 weeks after ad
riamycin injections. At week 1 they were randomly assigned to receive
no antihypertensive treatment, captopril 60 mg/kg per day or hydralazi
ne 6 mg/kg per day. A control group of SHR not treated with adriamycin
was also included in the study. Both antihypertensive agents normaliz
ed systemic blood pressure, but: failed to prevent proteinuria, mesang
ial expansion and renal failure progression. At the end of the study a
ll adriamycin-treated groups had the same degree of renal failure irre
spective of whether blood pressure was well controlled with captopril
or hydralazine or whether hypertension persisted. Nevertheless, antihy
pertensive therapy slowed down renal function deterioration in the ear
ly stage of adriamycin nephropathy. Treatment with captopril also redu
ced the development of glomerular sclerosis.